WAKMAR1: A Potential Drug Target for various Diseases (G105372576)
WAKMAR1: A Potential Drug Target for various Diseases
WAKMAR1 (LOC105372576) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The gene is located on chromosome 10 and has been shown to play a role in the development and progression of these diseases.
Research has shown that WAKMAR1 is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. The gene has been shown to be involved in the development of cancer, including breast, ovarian, and prostate cancer.
In addition to its role in cancer, WAKMAR1 has also been shown to be involved in the development of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Studies have shown that the gene is involved in the regulation of the aggregation of beta-amyloid particles, a hallmark of neurodegenerative disease, and that it may also be involved in the regulation of neurotransmitter levels.
Furthermore, WAKMAR1 has also been implicated in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Studies have shown that the gene is involved in the regulation of T cell function and that it may also be involved in the regulation of inflammation.
In conclusion, WAKMAR1 is a gene that has been shown to be involved in the development and progression of a wide range of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. As such, it is a potential drug target or biomarker for these conditions and further research is needed to fully understand its role in these processes.
Protein Name: Wound And Keratinocyte Migration Associated LncRNA 1
The "WAKMAR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WAKMAR1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
WAKMAR2 | WAPL | WARS1 | WARS2 | WARS2-AS1 | WAS | WASF1 | WASF2 | WASF3 | WASF4P | WASF5P | WASH complex | WASH2P | WASH3P | WASH4P | WASH5P | WASH6P | WASH7P | WASH8P | WASHC1 | WASHC2A | WASHC2C | WASHC3 | WASHC4 | WASHC5 | WASIR1 | WASL | WAVE1 complex | WBP1 | WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88
